Ornithine Transcarbamylase (OTC) Deficiency Treatment market is...

added blog Other

2024-08-21 12:06:08 - Translate -

Ornithine Transcarbamylase (OTC) Deficiency Treatment market is Anticipated to Witness Steady Growth

Ornithine transcarbamylase (OTC) deficiency is an inherited condition caused by a mutation in the gene responsible for the production of the enzyme OTC. The enzyme is responsible for clearing excess ammonia from the body. OTC deficiency mainly affects males and can lead to health issues like developmental delays, seizures, coma, and even death if left untreated. Treatment for OTC deficiency...

0 Comments 0 Shares 388 Views 0 Reviews